GOLDMAN MYLA LAI
CIK 1168581 · EVP & Chief Medical Officer · last filed 2026-05-06
GOLDMAN MYLA LAI is an EVP & Chief Medical Officer who has filed 62 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for WSTw, was dated May 6, 2026. Across all open-market trades the lifetime net is −$6.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $6.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$6.82M
5
62
-$6.85M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WSTw | Director | 20,434 | — | — | $0 | 25 | 2026-05-06 |
| QTRX | Director | 54,804 | $3.10 | $169.9K | $0 | 3 | 2026-01-06 |
| Akoya Biosciences, Inc. (AKYA) Delisted | Director | 20,000 | $1.29 | $25.8K | $100.0K | 5 | 2024-06-05 |
| SEQUENOM INC (SQNM) Delisted | Director | 0 | — | — | $18.4K | 10 | 2016-09-07 |
| LH | EVP & Chief Medical Officer | 24,990 | $266.16 | $6.65M | -$6.97M | 18 | 2008-11-24 |
Recent Filings
62 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-06 | WSTw | Grant (A) | +791 | $0 | EDGAR |
| 2026-01-06 | QTRX | Grant (A) | +25,316 | $0 | EDGAR |
| 2025-10-03 | QTRX | Grant (A) | +2,084 | $11.5K | EDGAR |
| 2025-07-10 | — | Other (J) | −20,000 | $0 | |
| 2025-07-10 | QTRX | Grant (A) | +27,404 | $0 | EDGAR |
| 2025-05-08 | WSTw | Grant (A) | +1,071 | $0 | EDGAR |
| 2024-06-05 | Akoya Biosciences, Inc. (AKYA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-04-25 | WSTw | Grant (A) | +564 | $0 | EDGAR |
| 2023-06-12 | Akoya Biosciences, Inc. (AKYA) Delisted | Buy (P) | +20,000 | $100.0K | EDGAR |
| 2023-06-05 | Akoya Biosciences, Inc. (AKYA) Delisted | Grant (A) | — | $0 | EDGAR |